Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FotoPharmacy is a biotechnology company pioneering the field of photopharmacology to develop light-activated therapeutic agents. By incorporating molecular photoswitches into small molecule drugs, the company creates "smart" medicines that can be precisely controlled in space and time using light. Their primary focus is on vision restoration for patients with degenerative retinal diseases, such as retinitis pigmentosa, where light-sensitive molecules can restore visual function by bypassing damaged photoreceptors. Additionally, FotoPharmacy is developing localized treatments for chronic pain and oncology to minimize systemic side effects and improve therapeutic indices. The company was co-founded by world-renowned experts in chemical biology and photopharmacology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FotoPharmacy.